Suppr超能文献

148例肾细胞癌中14号染色体等位基因失衡与不良预后参数的相关性

Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.

作者信息

Béroud C, Fournet J C, Jeanpierre C, Droz D, Bouvier R, Froger D, Chrétien Y, Maréchal J M, Weissenbach J, Junien C

机构信息

INSERM U383, Hôpital Necker-Enfants Malades, Université René Descartes Paris V, France.

出版信息

Genes Chromosomes Cancer. 1996 Dec;17(4):215-24. doi: 10.1002/(SICI)1098-2264(199612)17:4<215::AID-GCC3>3.0.CO;2-6.

Abstract

To investigate cumulative genetic alterations during development and progression of renal cell carcinoma (RCC), we examined DNAs that were isolated from 148 RCCs for allelic imbalance (AI) at four loci on chromosome arm 3p and at 26 loci on chromosome arm 14q by using polymorphic microsatellite markers and densitometric scanning. Because the analysis of solid tumor unbalanced rearrangements remains difficult due to the large proportion of cells that infiltrate from the stroma, we developed a method for the detection and quantification of AI between control and tumor samples by using polymerase chain reaction (PCR) amplification of microsatellite markers. This technique allows detection down to 20% of contaminating cells with good accuracy. We detected AI on 3p and 14q in 57 and 28% of RCC, respectively. A comparison of genetic changes with clinicopathological data showed that, in marked contrast to AI on 3p, AI on 14q was correlated significantly with the stage and grade of the tumors, with 56 and 58% of RCC in Stage IV and Grade 4, respectively, showing AI. Our results suggest that tumor suppressor genes on 3p, including the von Hippel-Lindau gene, may be involved in early steps of carcinogenesis in clear cell carcinoma and that AI on 14q may play an important role in the progression of clear cell and papillary chromophilic cell carcinomas. Loss of heterozygosity (LOH) on 14q may be a new prognostic factor in RCC. Despite the size of the series of tumors and the number of markers used, only rearrangements that involved the whole length of the long arm of chromosome 14 were observed in the present study. The localization of the putative tumor suppressor gene on 14q will require further investigation of RCC with structural rearrangements of 14q.

摘要

为了研究肾细胞癌(RCC)发生发展过程中的累积基因改变,我们使用多态性微卫星标记和光密度扫描技术,检测了从148例RCC中分离出的DNA在染色体3p臂上的4个位点以及14q臂上的26个位点的等位基因失衡(AI)情况。由于实体瘤中大量细胞来源于基质浸润,使得对其不平衡重排的分析仍然困难,因此我们开发了一种利用微卫星标记的聚合酶链反应(PCR)扩增来检测和定量对照与肿瘤样本间AI的方法。该技术能够准确检测低至20%的污染细胞。我们分别在57%和28%的RCC中检测到了3p和14q上的AI。基因改变与临床病理数据的比较显示,与3p上的AI形成显著对比的是,14q上的AI与肿瘤分期和分级显著相关,IV期和4级RCC中分别有56%和58%显示AI。我们的结果表明,3p上的肿瘤抑制基因,包括冯·希佩尔-林道基因,可能参与了透明细胞癌的早期致癌过程,而14q上的AI可能在透明细胞癌和嗜酸性乳头状细胞癌的进展中起重要作用。14q上的杂合性缺失(LOH)可能是RCC的一个新的预后因素。尽管本研究中的肿瘤样本数量和使用的标记数量较多,但仅观察到涉及14号染色体长臂全长的重排。14q上假定的肿瘤抑制基因的定位需要对具有14q结构重排的RCC进行进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验